Starpharma Holdings Limited (PQ6) Income Statement
Starpharma Holdings Limited Income Statement
Last quarter (Q4 2026), Starpharma Holdings Limited's total revenue was $1.22M, a decrease of 29.64% from the same quarter last year. In Q4, Starpharma Holdings Limited's net income was $-8.83M. See Starpharma Holdings Limited’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| $ 12.05M | $ 4.91M | $ 8.29M | $ 2.94M | $ 4.68M | |
| $ 10.39M | $ 3.69M | $ 7.66M | $ 1.22M | $ 1.91M | |
| $ 29.63M | $ 15.69M | $ 22.82M | $ 25.90M | $ 25.80M | |
| Depreciation and Amortization | $ 911.00K | $ 1.07M | $ 1.11M | $ 1.19M | $ 1.08M |
| $ -18.32M | $ -10.93M | $ -9.63M | $ -22.08M | $ -22.34M | |
| $ -19.23M | $ -12.00M | $ -15.16M | $ -24.67M | $ -23.89M | |
| $ 618.00K | $ 2.01M | $ 1.47M | $ 1.40M | $ 480.00K | |
| $ -18.61M | $ -9.99M | $ -13.69M | $ -23.27M | $ -23.41M | |
| $ -7.46M | $ -9.99M | $ -8.16M | $ -15.64M | $ -16.15M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.02 | $ -0.02 | $ -0.02 | $ -0.04 | $ -0.04 |
| Diluted EPS | $ -0.02 | $ -0.02 | $ -0.02 | $ -0.04 | $ -0.04 |
| Weighted Average Shares Outstanding | 430.82M | 417.18M | 408.25M | 390.96M | 403.85M |
| Weighted Average Shares Outstanding (Diluted) | 430.82M | 417.18M | 411.43M | 409.04M | 406.90M |
Currency in AUD
